Seeking Alpha

David Greene

 
View as an RSS Feed
View David Greene's Articles BY TICKER:
  • Digesting The GMO Food Controversy And What It Means For Your Investment Portfolio
    Thu, Jul. 10 MON, DOW, WFM 15 Comments

    Summary

    • Monsanto (MON) and other Genetically Modified (GM) seed companies may be impacted by increased consumer awareness.
    • Natural/Organic Grocers such as Whole Foods (WFM) will benefit from shift to non-GMO foods by consumers interested in their health and willing to pay for it.
    • Small agriculture service companies like Verity Corp (VRTY) have a significant opportunity to grow rapidly as farmers transition to non-GMO food production.
  • American Society Of Clinical Oncology Abstracts Point To Potential Profits
    May. 21, 2013 BAX, BSX, CLVS 3 Comments
  • 2 Promising Medical Companies Near Their Lows
    May. 24, 2012 BSX, DNDN, MDT 12 Comments
  • Medical Device Companies May Have Eyes On Non-Invasive Alternative Technology
    Sep. 15, 2011 BSX, SYK, MDT 37 Comments
  • Time For Some Sunshine For Canadian Solar Shareholders
    Sep. 7, 2011 CSIQ 5 Comments
  • A Fistful Of Dollars At Family Dollar Stores
    Sep. 2, 2011 WMT, TGT, BIG 4 Comments
  • Waiting for the Other Shoe to Drop at American Superconductor
    Jun. 8, 2011 AMSC 3 Comments
  • Why Competititve Technologies Could Be Ridiculously Undervalued
    May. 15, 2011 CTTC 26 Comments
  • In the Logistics Industry, Does a Rising Tide Lift All Boats?
    Dec. 21, 2010 PACR, UPS, FDX Comment!
  • Does Orexigen's Success at FDA Pave a Path for Other Obesity Drug Manufacturers?
    Dec. 9, 2010 OREX, ABT, VVUS 3 Comments
  • Competitive Technologies: More Frequent Sales to Come?
    Oct. 6, 2010 CTTC 12 Comments
  • Will the FDA Give Vivus More Time Before the Final Judgment on Qnexa?
    Sep. 26, 2010 VVUS 3 Comments
  • Weighty Issues With Vivus Take a Turn for the Better
    Sep. 24, 2010 VVUS 3 Comments
  • Crocs: Gaining Traction Going Into Christmas
    Sep. 24, 2010 CROX, NKE, SKX Comment!
  • Competitive Technologies: Short Squeeze Coming or Another Leg Down?
    Aug. 25, 2010 CTT, ABIO, ABT 29 Comments
  • No Bleeding at Haemonetics
    Aug. 23, 2010 HAE Comment!
  • Pain Relief Coming at Competitive Technologies?
    Jul. 6, 2010 CTT 4 Comments
  • Amgen Likely to React Dramatically to Early FDA Approval of Osteoporosis Drug
    Jun. 2, 2010 AMGN, NVS 2 Comments
  • Delcath: Clinical Results for Melanoma Treatment More Than Skin Deep
    May. 20, 2010 DCTH 15 Comments
  • Competitive Technologies: A Game Changer in Pain Management?
    May. 14, 2010 CTT, ABT, GE 11 Comments
  • Competitive Technologies Up on Shareholder Meeting, Pending ASCO Presentation
    Apr. 22, 2010 CTT 21 Comments
  • Competitive Technologies: Is the Pain Over?
    Apr. 14, 2010 CTT Comment!
  • GenVec Is Not Just a One Trick Pony
    Mar. 15, 2010 GNVC, NVS 22 Comments
  • Cell Therapeutics: The Jury's Still Out on Pixatrone
    Mar. 10, 2010 GSK, ABT, PGNX 39 Comments
  • A Possible New Indication for Progenix's Relistor Could Revive Its Fortunes
    Nov. 20, 2009 PGNX Comment!
  • CTT's Pain Mangement Device Sales to Result in Positive Surprise in 10Q
    Nov. 19, 2009 IART, AFFX, RDNT 2 Comments
  • Progenics: Are the Prospects That Bad?
    Nov. 16, 2009 GSK, WYE, PGNX Comment!
  • Competitive Technologies: FDA-Approved Medical Device Hitting the Revenue Line
    Nov. 9, 2009 CTT Comment!
  • Don't Throw Thornburg Mortgage into the Briarpatch Yet
    Mar. 4, 2008 THMR 2 Comments
  • High Tide for SiRF Technology
    Feb. 24, 2008 SIRF 20 Comments